Yoshiki Takahashi

Yoshiki Takahashi

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2012 in Blood Purification
Verified
Journal Article
Open access
NTNaoshi Takeyama
Naoshi Takeyama
HNHiroshi Noguchi
Hiroshi Noguchi
AHAkihiko Hirakawa
Akihiko Hirakawa
HKHideki Kano
Hideki Kano
KMKazuma Morino
Kazuma Morino
JGJapan Sepsis Study Group
Japan Sepsis Study Group
Background: We investigated whether early initiation of hemoperfusion with a polymyxin B cartridge (PMX) after the diagnosis of septic shock could improve the clinical outcome. Methods: A prospective, open-labeled, multicenter cohort study was performed at intensive care units in Japan. 41 patients received PMX within 6 h after the diagnosis of septic shock (early group) and 51 patients were treated after 6 h (late group). Results: The early group had a significantly shorter duration of ventilator support and also had a lower catecholamine requirement. PMX was effective for improvement of hypotension, hypoperfusion, the sequential organ failure assessment score, and pulmonary oxygenation regardless of the timing of its initiation. The 28-day mortality rate did not differ between the two groups. Conclusions: Early initiation of PMX shortened the duration of ventilator support and also reduced the catecholamine requirement, so early treatment of septic shock should achieve a better outcome.

1 March 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
EIEri Inoue
Eri Inoue
YTYoshiki Takahashi
Yoshiki Takahashi
YIYoshio Imai
Yoshio Imai
TKTetsuya Kamataki
Tetsuya Kamataki

28 September 2020 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
YTYoshiki Takahashi
Yoshiki Takahashi
NTNaonobu Takahira
Naonobu Takahira
KUKatsufumi Uchiyama
Katsufumi Uchiyama
KFKensuke Fukushima
Kensuke Fukushima
MMMitsutoshi Moriya
Mitsutoshi Moriya
MTMasashi Takaso
Masashi Takaso
Background: Curved periacetabular osteotomy (CPO) was developed to treat acetabular dysplasia. Given that CPO can improve physical function in the early post-operative period, patients might be able to participate in sports activities post-operatively. Therefore, this study examined the post-operative sports activity participation and characteristics of acetabular dysplasia patients who have undergone CPO.Methods: A total of 52 patients who underwent CPO for acetabular dysplasia were given a questionnaire on pre- and post-operative sports activities; 43 patients responded. We surveyed patients’ sports activities, satisfaction, and physical function. Patients were divided according to whether they participated in sports activities after CPO. Physical function was compared before and after CPO.Results: The pre- and post-operative sports activity participation rates were 55.8 and 72.1%, respectively. Patients mostly performed low-impact sports activities. Moreover, patients who participated in sports activities post-operatively had smaller pre-operative range of motion of hip flexion and returned to full weight bearing earlier.Conclusions: Among acetabular dysplasia patients who underwent CPO, 72.1% participated in sports activities post-operatively. Post-operatively, patients participated not only in low-impact sports activities, but also in high-impact ones. These findings might be useful for advising patients who are concerned about participating in sports activities after CPO.

30 March 2007 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JKJunzo Kamei
Junzo Kamei
SHShun-Suke Hayashi
Shun-Suke Hayashi
YTYoshiki Takahashi
Yoshiki Takahashi
CNChihiro Nozaki
Chihiro Nozaki

28 October 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
Keita WagatsumaKeita Wagatsuma
Keita Wagatsuma
RSRyosuke Sato
Ryosuke Sato
SYSatoru Yamazaki
Satoru Yamazaki
MIMasako Iwaya
Masako Iwaya
YTYoshiki Takahashi
Yoshiki Takahashi
Reiko SaitoReiko Saito
Reiko Saito
The coronavirus disease 2019 (COVID-19) has caused a serious disease burden and poses a tremendous public health challenge worldwide. Here, we report a comprehensive epidemiological and genomic analysis of SARS-CoV-2 from 63 patients in Niigata City, a medium-sized Japanese city, during the early phase of the pandemic, between February and May 2020. Among the 63 patients, 32 (51%) were female, with a mean (±standard deviation) age of 47.9 ± 22.3 years. Fever (65%, 41/63), malaise (51%, 32/63), and cough (35%, 22/63) were the most common clinical symptoms. The median Ct value after the onset of symptoms lowered within 9 days at 20.9 cycles (interquartile range, 17–26 cycles), but after 10 days, the median Ct value exceeded 30 cycles (p < 0.001). Of the 63 cases, 27 were distributed in the first epidemic wave and 33 in the second, and between the two waves, three cases from abroad were identified. The first wave was epidemiologically characterized by a single cluster related to indoor sports activity spread in closed settings, which included mixing indoors with families, relatives, and colleagues. The second wave showed more epidemiologically diversified events, with most index cases not related to each other. Almost all secondary cases were infected by droplets or aerosols from closed indoor settings, but at least two cases in the first wave were suspected to be contact infections. Results of the genomic analysis identified two possible clusters in Niigata City, the first of which was attributed to clade S (19B by Nexstrain clade) with a monophyletic group derived from the Wuhan prototype strain but that of the second wave was polyphyletic suggesting multiple introductions, and the clade was changed to GR (20B), which mainly spread in Europe in early 2020. These findings depict characteristics of SARS-CoV-2 transmission in the early stages in local community settings during February to May 2020 in Japan, and this integrated approach of epidemiological and genomic analysis may provide valuable information for public health policy decision-making for successful containment of chains of infection.

1 January 2020 in Journal of Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
YTYoshiki Takahashi
Yoshiki Takahashi
NTNaonobu Takahira
Naonobu Takahira
MSManaka Shibuya
Manaka Shibuya
KUKatsufumi Uchiyama
Katsufumi Uchiyama
KFKensuke Fukushima
Kensuke Fukushima
MTMasashi Takaso
Masashi Takaso
Purpose: There is a pressing need for safe venous thromboembolism (VTE) prophylaxis in orthopedic patients with the highest risks of both venous thrombosis and bleeding. Portable intermittent pneumatic compression device (IPCD) has proven to be effective and safe in patients with a high risk of venous thrombosis and low bleeding risk. Therefore, this study examined the effectiveness, safety, and wearing compliance of portable IPCD for postoperative VTE prophylaxis in patients with the highest risks of both venous thrombosis and bleeding. Methods: The cases consisted of 38 patients who had used a portable IPCD and had the highest risks of both venous thrombosis and bleeding. We examined the incidence of VTE to assess the effectiveness of the portable IPCD, the presence of hemorrhagic adverse events to assess safety, and the wearing rate to assess wearing compliance. Results: The incidences of asymptomatic and symptomatic deep vein thrombosis were 5.3% and 2.6%, respectively. The incidence of hemorrhagic adverse events was 21.1% in patients who received anticoagulants and wore an IPCD simultaneously and 0% in patients who wore an IPCD but did not receive anticoagulants. The wearing rate (i.e. ≥18 h/day) was 100%. Conclusion: Portable IPCD has the potential for safe VTE prophylaxis in patients at high risks for both venous thrombosis and bleeding. Therefore, we suggest that such patients use a portable IPCD for VTE prophylaxis.